Search Keyword:


Search option:


IID00441
UniprotP15336
ProteinCyclic AMP-dependent transcription factor ATF-2
GeneATF2
OrganismHomo sapiens
Sequence LLPS PhaSepDB
PhaSePro
LLPSDB
DrLLPS
Network xml rdf
Structure
Experiment
  :order   disorder   conflict   PDB cluster   ProS   Pfam Domain   SEG
505
 order/disorder by at least rule
     disorder by at least rule
     order by at least rule
 order/disorder by majority rule
Seq 19-56 Monomer :
 Evidence NMR 1bhi A Reference
       Region 1bhi A 19-56 order
       Region 1bhi A 19-22 high_rmsd
       Region 1bhi A 53-56 high_rmsd
Seq 48-55 Hetero dimer : IID00456Complex
 Evidence X-RAY 4h36 B Reference
       Region 4h36 B 48-55 order
Seqdisorder 57-106
 Evidence NMR Reference
       Region 57-106 disorder
Seq 354-414 Hetero tetramer : IID00079Complex,IID00437Complex
 Evidence X-RAY 1t2k D Reference
       Region 1t2k D 354-414 order
Seqphosphorylation
    52-52 Phosphothreonine; by PKC/PRKCH
    69-69 Phosphothreonine; by MAPK11 and MAPK14
    62-62 Phosphoserine; by VRK1
    71-71 Phosphothreonine; by MAPK1
    73-73 Phosphothreonine; by VRK1
    490-490 Phosphoserine; by ATM
    498-498 Phosphoserine; by ATM
    446-446 Phosphoserine
    90-90 Phosphoserine
    442-442 Phosphoserine
    367-367 Phosphoserine; by PKC/PRKCA and PKC/PRKCB
    328-328 Phosphoserine
    340-340 Phosphoserine; by PKC/PRKCA and PKC/PRKCB
    136-136 Phosphoserine
    121-121 Phosphoserine; by PKC/PRKCA and PKC/PRKCB
    112-112 Phosphoserine
    116-116 Phosphothreonine
Seqacetylation
    374-374 N6-acetyllysine
    357-357 N6-acetyllysine
 
Prediction
NeProc
Disorder 75-78,87-90,98-376,430-505
Order 1-16,23-74,79-86,91-97,377-429
ProS 75-78,87-90,113-119,146-150,161-167,176-183,192-196,206-222,247-256,275-285,324-329,353-376
AlphaFold
Disorder 1-22,52-215,230-272,283-348,427-505
Order 23-51,216-229,273-282,349-426
Pfam Hmmer
PF00096 25-49 0.00096
PF00170 350-414 3.1e-13
SEG 255-272 ,318-334 ,455-467
Function
Function in SwissProt
Transcriptional activator which regulates the transcription of various genes, including those involved in anti-apoptosis, cell growth, and DNA damage response. Dependent on its binding partner, binds to CRE (cAMP response element) consensus sequences (5'-TGACGTCA-3') or to AP-1 (activator protein 1) consensus sequences (5'-TGACTCA-3'). In the nucleus, contributes to global transcription and the DNA damage response, in addition to specific transcriptional activities that are related to cell development, proliferation and death. In the cytoplasm, interacts with and perturbs HK1- and VDAC1-containing complexes at the mitochondrial outer membrane, thereby impairing mitochondrial membrane potential, inducing mitochondrial leakage and promoting cell death. The phosphorylated form (mediated by ATM) plays a role in the DNA damage response and is involved in the ionizing radiation (IR)-induced S phase checkpoint control and in the recruitment of the MRN complex into the IR-induced foci (IRIF). Exhibits histone acetyltransferase (HAT) activity which specifically acetylates histones H2B and H4 in vitro (PubMed:10821277). In concert with CUL3 and RBX1, promotes the degradation of KAT5 thereby attenuating its ability to acetylate and activate ATM. Can elicit oncogenic or tumor suppressor activities depending on the tissue or cell type.